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INTRODUCTION:  Rectovaginal  ﬁstulas  have  a multitude  of causes  and  it is well  known  that  obstetric  and
gynecological  problems  form  a large  part  of  these  causes  such  as  our  case.
PRESENTATION OF  CASE:  We  present  a 45-year-old  female  that  presented  with  complaints  of stool  per
vagina  and  was  found  to have  a  rectal  vaginal  ﬁstula  near  the  vaginal  cuff  from  her previous  uncomplicated
vaginal  hysterectomy.  The  patient  was  originally  scheduled  for a  complex  open  abdominal  surgery  based
on  examination  but  underwent  a sigmoidoscopy  with  vaginal  examination  and  identiﬁed  a  small  opening
with  minimal  inﬂammation.  The  patient  was  treated  with  Bioglue® and  had  complete  resolution  of  theioglue
nal  ﬁstula
ﬁstula  at  follow-up.
DISCUSSION:  There  are  numerous  cases  presented  in  the  literature  on the use of  bioglue for anal  ﬁstulas
and  rectovaginal  ﬁstulas  with  multiple  cases  of  success.  However,  in  looking  at  the  literature  failure
appears  to be  due  to ongoing  inﬂammation  from  the  previous  disease  process.
CONCLUSION: Although  the  use  of Bioglue® may  not  be suitable  for  all  patients  with  rectovaginal  ﬁstulas,
it  offers  yet  another  treatment  modality  for select  patients.
gical 
well known that obstetric and gynecological problems form a large
part of those causes.1 Classiﬁcation of the ﬁstulas is based on the
location in relationship to the cervix and vaginal fourchette with
low lying being near the later and high ﬁstulas near the cervix. It is
.© 2012 Sur
. Case presentation
We  present a 45-year-old female that presented with com-
laints of stool per vagina for 3 months. Her past medical history
as signiﬁcant for an uncomplicated vaginal hysterectomy per-
ormed in 2006 for endometriosis. Initial exam did not reveal ﬁstula,
ubsequent exam with manual digital pressure showed small open-
ng. Vaginal examination conﬁrmed the presence of fecal stream
rom the posterior vaginal cuff with an opening of less than 5 mm
dentiﬁed as a high ﬁstula. The patient was referred to our general
urgery clinic for possible rectovaginal ﬁstula surgical repair. Pre-
ious computed tomography of the pelvis demonstrated an area
f inﬂammation between the rectum and vagina at the same loca-
ion (Fig. 2). A bowel prep was performed and patient underwent
exible sigmoidoscopy which failed to identify the ﬁstula tract.
owever, on examination of the vaginal cuff with speculum exam
id reveal the area of suspicion and was conﬁrmed with expres-
ion of small amount stool (Fig. 1). A 5-mL syringe of commercial
uriﬁed bovine serum albumin (BSA) and glutaraldehyde surgical
dhesive (BioGlue®, CryoLife, Inc., Atlanta, GA) was applied to the
rea and patient discharged home with instructions to continue a
ow residue diet and abstain from sexual activity until follow-up in
linic. At return to our clinic at 3 weeks, she had complete resolu-
ion of stooling from her vagina and at 6 month follow-up remained
ymptom free.
∗ Corresponding author. Tel.: +1 210 275 3604.
E-mail address: sharmila.dissanaike@ttuhsc.edu (S. Dissanaike).
210-2612     ©  2012 Surgical Associates Ltd. Published by Elsevier Ltd. 
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2. Discussion
Rectovaginal ﬁstulas (RVF) have a multitude of causes and it is
Open access under CC BY-NC-ND licenseFig. 1. Endoscopy of vagina with black arrow pointing to ﬁstula.
 BY-NC-ND license.
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Table 1
Summary of cases in the literature of repair of rectovaginal ﬁsutulas using bioglue
or  equivalent.
Author Agent Follow-up Outcome/# of
cases
Abel et al.6 Fibrin glue 3–12 months 4 of 5 healed
ﬁstula (80%)
Ortiz-Mayano et al.5 (Histoacryl)
and resolution
clips
2  months Resolution of
ﬁstula
One  case
Alexander et al.7 Bioglue Not  reported Failed
One case
De la Portillia et al.8 Bioglue 3–21 months Cure rate in 7
patients  (50%)
De  la Portillia et al.9 Bioglue 60 months New cure rate
in  original 7
patients  only 3
patients
remainedig. 2. CT of pelvis with red arrow pointing to inﬂammation at the rectovaginal
eptum.
lso important to classify RVF into simple and complex due to the
ifferent treatment algorithms.2 Simple ﬁstulas are deﬁned as low
ying ﬁstulas, less than 2.5 cm in size, and associated with simple
rauma or infection. Complex RVFs are deﬁned as size greater than
.5 cm,  high ﬁstulas near the cervix, associated with inﬂammatory
owel disease, or are recurrent.2
Simple RVFs can be repaired using the endo-rectal advancement
ap, however, complex RVFs involve larger surgeries. In high RVFs
he transabdominal approach is often sited with the repair involv-
ng interposition of healthy tissue between the rectum and vagina
ith surgical modalities including low anterior resections, abdom-
nal perineal resections, and complex muscle ﬂaps.1,2 Our patient
ad a high ﬁstula, which would have required a transabdominal
urgical repair, however, we were able to treat here ﬁstula with the
ioglue. How bioglue works has been deﬁned and the novel surgi-
al adhesive Bioglue (CryoLife, Kennesaw, GA) provides a four times
tronger bond than ﬁbrin glue. It is composed of bovine serum albu-
in  and glutaraldehyde, molecules which covalently bond together
s well as to the tissue proteins at the repair site, creating a ﬂexi-
le mechanical seal. It remains intact for up to 2 years and is then
esorbed slowly and replaced by normal tissue without causing a
hronic inﬂammatory state.7
There has been a lot of interest in less invasive procedure with
he introduction of bioprosthetic ﬁstula plug made from porcine
ntestinal submucosa (Anal Fistula Plug, Cook Surgical, Inc., Bloom-
ngton, IN). Although original designed for anal ﬁstulas, has moved
nto being used for RVFs with success and continues to be evaluated
nd has been studied in randomized clinical trials comparing surgi-
al versus ﬁstula plug with mixed results.3,4 There have also been a
ew case reports of the use of ﬁbrin or bioglue for the repair of RVFs,
ut only in a few select patients has it been successful.5,6 One case
eported the use of histoacryl as a sealant placed between endoclips
fter a 78-year-old female refused surgery and at follow-up was
symptomatic at 2 months.5 Abel et al. had the largest case report
eries with ten patients treated with a ﬁbrin glue for a mixture of
omplex RVFs with 60% of patients having complete healing of the
stula.6 The reported failures were due to immuno-compromised
tates due to Crohn’s disease and HIV, but the patients still reported
ecreased drainage.6
The use of bioglue is not a novel idea and has been used in
he treatment of anal ﬁstulas with some success with cure rates
eported at 50%. However, one study treated eight patients with not
o promising results. Seven patients identiﬁed had transspheteric
nal ﬁstulas and one had a rectovaginal ﬁstula. The anal ﬁstulaasymptomatic
(21%)
group underwent transanal advancement ﬂap repair with bioglue
and the RVF patient had bioglue alone. Of the eight patients only
one patient had complete resolution of the ﬁstula tract with the
others suffering complications of pain, abscess, and persistent ﬁs-
tula tract. Due to these complications the study was ended sooner.
One explanation given for the failure could have been due to the
persistence of inﬂammation after the procedure.7
De la Portillia et al. used bioglue to seal ﬁstula tracts in 14
patients after curettage with a reported cure rate of 50% after a
follow up mean period of 13.9 months.8 The group recently pub-
lished a 60 month follow up of the original seven patients that had a
cure and of that group only three patients remained asymptomatic
with a new cure rate of 21%.9
There are various smaller cases of recurrent RVFs treated with
bioglue with some success sited together with other surgical
modalities. One group used bioglue for the repair of recurrent recto-
vaginal ﬁstulas in three patients, one with bioglue and the other two
with mucosal advancement ﬂaps (MAF) and bioglue. The two MAF
with bioglue failed yet the one with the bioglue alone resolved.9
Again as seen with the failure of the anal ﬁstula group above, they
attributed failure due to either inﬂammation, hematoma, tension,
or underlying disease (e.g. Crohn’s).10 In summary Table 1 shows
an easy format to look at the above discussed cases of rectovagi-
nal ﬁstulas that have been treated with some form of glue and the
outcomes.
3. Conclusion
Rectovaginal ﬁstulas have well deﬁned etiologies and depend-
ing on their classiﬁcation of simple or complex will deﬁne their
treatment. We  have presented a unique treatment, deﬁned in the
literature with a few case reports, of the use of bioglue to repair
a rectovaginal ﬁstula. This allowed outpatient, noninvasive cure
without resorting to laparotomy and surgical repair, with obvi-
ous beneﬁt to the patient. Although the use of bioglue may  not be
suitable for all patients with RVFs, it offers yet another treatment
modality for selected patients.
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